When sourcing peptides for laboratory research, purity is arguably the most critical specification to verify. A peptide marketed as “99% pure” without supporting analytical data is a marketing claim, not a scientific guarantee. This article explains the analytical methods used to determine peptide purity and why independent testing is a prerequisite for reliable research outcomes.
What Does “Purity” Mean for a Research Peptide?
Purity refers to the proportion of the intended peptide sequence present in the final product, as a percentage of total peptide content. Impurities can include:
- Deletion sequences (amino acids missed during solid-phase synthesis)
- Oxidation products (particularly of methionine and cysteine residues)
- Residual protecting groups from synthesis
- Aggregated or misfolded species
- Synthesis by-products and truncated sequences
Each of these contaminants can affect experimental outcomes differently, from altered receptor binding affinity to off-target biological effects — making their characterisation essential for reproducible research.
High-Performance Liquid Chromatography (HPLC)
Reverse-phase HPLC (RP-HPLC) is the gold standard method for peptide purity analysis. In RP-HPLC, the peptide sample is injected into a column packed with a non-polar stationary phase (typically C18). The mobile phase — a gradient of aqueous buffer and organic solvent (commonly acetonitrile with 0.1% TFA) — separates components based on their hydrophobicity.
The instrument produces a chromatogram showing UV absorbance (typically at 214nm or 220nm) over elution time. The main peptide peak area is expressed as a percentage of total peak area — this is the reported purity figure. At Imperial Peptide, all products are required to achieve ≥99% purity by this method before being released for sale.
Mass Spectrometry: Confirming Identity
Purity tells you how much of the compound is present, but not what the compound is. Mass spectrometry (MS) — typically electrospray ionisation MS (ESI-MS) or matrix-assisted laser desorption/ionisation time-of-flight MS (MALDI-TOF) — confirms molecular weight, and therefore peptide identity, by comparing the measured m/z ratio to the theoretical molecular weight of the target sequence.
A supplier providing only HPLC data without mass spectrometry confirmation cannot fully guarantee that the correct peptide is present at the stated purity. Both analyses together constitute a minimum standard for research-grade material.
Reading a Certificate of Analysis
A complete Certificate of Analysis (CoA) from a reputable testing laboratory should include: the peptide name and sequence, molecular formula and weight, batch number, synthesis date, testing date, laboratory name and accreditation, HPLC chromatogram and purity figure, and MS spectrum with observed vs. theoretical molecular weight. Imperial Peptide publishes batch-specific CoAs in the Testing Archive so researchers can review documentation before placing an order.
